Signaling Pathways - Bromodomains - Insulin and Insulin-like Receptors
清除全部
- B1013 GSK1324726ATarget: BromodomainsSummary: BET蛋白抑制剂
- B1012 MS436Target: BromodomainsSummary: BRD4抑制剂
- B1498 I-BET-7624 CitationTarget: BromodomainsSummary: BET抑制剂
- A8440 GSK1838705ATarget: Insulin and Insulin-like Receptors|ALKSummary: ATP竞争性IGF-IR/IR/ALK抑制剂
- A1302 GSK1904529ATarget: Insulin and Insulin-like ReceptorsSummary: IGF-1R/IR 选择性抑制剂
- A1185 BMS-754807Target: Insulin and Insulin-like ReceptorsSummary: 有效的、选择性的IGF-1R和InsR抑制剂
- A3692 OTX-0153 Citation中文名: 比拉瑞塞Target: BromodomainsSummary: BRD抑制剂
- A3608 MK 0893Target: Insulin and Insulin-like Receptors|Glucagon ReceptorsSummary: 胰高血糖素受体/ IGF-1R拮抗剂
- A4302 Rosiglitazone maleate中文名: 马来酸罗格列酮Target: Insulin and Insulin-like ReceptorsSummary: PPARγ激动剂,有效的胰岛素敏化剂
- A1910 Bromodomain Inhibitor, (+)-JQ138 CitationTarget: BromodomainsSummary: BET bromodomain抑制剂。